NCT01965509View on ClinicalTrials.gov

A PK/PD Study of Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

August 31, 2013

Study Completion Date

October 31, 2013

Conditions
Type 2 Diabetes
Interventions
DRUG

PEX168 or placebo

injection has to administered subcutaneously weekly

Trial Locations (1)

Unknown

China-Japan Friendship Hospital, Beijing

All Listed Sponsors
collaborator

China-Japan Friendship Hospital

OTHER

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY

NCT01965509 - A PK/PD Study of Polyethylene Glycol Loxenatide in Patients With Type 2 Diabetes | Biotech Hunter | Biotech Hunter